GE HealthCare announced US FDA 510K clearance of Critical Care Suite 2.1 featuring a Pneumothorax algorithm for the detection, notification, triage and diagnosis of PTX. The updated PTX algorithm expands Critical Care Suite’s on-device triage capabilities by providing immediate notification of the presence or absence of pneumothorax, as well as an overlay display both on-device and in PACS to assist with PTX localization, GE HealthCare said.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on GEHC:
- iCAD announces AI solutions to be offered in new MyBreastAI offering
- Roku upgraded, Lucid Group downgraded: Wall Street’s top analyst calls
- GE HealthCare downgraded to Sell from Neutral at UBS
- GE HealthCare announces new version of Digital Expert Access, deal with IONIC
- GE HealthCare, BAMF Health collaborate for Theranostics solutions